+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Microbiomes Market 2020-2024 - Product Image

Global Microbiomes Market 2020-2024

  • ID: 4994835
  • Report
  • March 2020
  • Region: Global
  • 120 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • 4D pharma Plc
  • ENTEROME SA
  • Evelo Biosciences Inc.
  • Osel Inc.
  • Second Genome Inc.
  • Seres Therapeutics Inc.
  • MORE
Global Microbiomes Market 2020-2024.

The publisher has been monitoring the global microbiomes market 2020-2024 and it is poised to grow by USD 544.72 mn during 2020-2024, progressing at a CAGR of 30% during the forecast period. The report on the global microbiomes market 2020-2024 provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of diseases. In addition, growing focus on developing biosensors and genetic circuits is anticipated to boost the growth of the global microbiomes market 2020-2024 as well.

Market Segmentation

The publisher's global microbiomes market 2020-2024 is segmented as below:

Application:
  • Therapeutics
  • Diagnostics
Geographic Segmentation:
  • Asia
  • Europe
  • North America
  • ROW
Key Trends for global microbiomes market 2020-2024 growth

This study identifies growing focus on developing biosensors and genetic circuits as the prime reasons driving the global microbiomes market 2020-2024 growth during the next few years.

Prominent vendors in global microbiomes Market 2020-2024.

The publisher provides a detailed analysis of around 25 vendors operating in the global microbiomes market 2020-2024, including some of the vendors such as 4D pharma Plc, ENTEROME SA, Evelo Biosciences Inc., Ferring International Center SA, Osel Inc., Second Genome Inc., Seres Therapeutics Inc., Synlogic Inc., Synthetic Biologics Inc. and Vedanta Biosciences Inc. .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 4D pharma Plc
  • ENTEROME SA
  • Evelo Biosciences Inc.
  • Osel Inc.
  • Second Genome Inc.
  • Seres Therapeutics Inc.
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
  • Five Forces Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Application
  • Market segments
  • Comparison by Application placement
  • Therapeutics - Market size and forecast 2019-2024
  • Diagnostics - Market size and forecast 2019-2024
  • Market opportunity by Application
Customer landscape
  • Overview
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
Drivers, Challenges, and Trends
  • Market drivers
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Volume driver - Demand shift in adjacent markets
  • Price driver - Inflation
  • Price driver - Shift from lower to higher-priced units
  • Market challenges
  • Market trends
Vendor Landscape
  • Overview
  • Vendor landscape
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • 4D Pharma Plc
  • ENTEROME SA
  • Evelo Biosciences, Inc.
  • Ferring International Center SA
  • Osel Inc.
  • Second Genome Inc.
  • Seres Therapeutics Inc.
  • Synlogic Inc.
  • Synthetic Biologics Inc.
  • Vedanta Biosciences Inc.
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
1. Key Finding 1
2. Key Finding 2
3. Key Finding 3
4. Key Finding 4
5. Key Finding 5
6. Key Finding 6
7. Key Finding 7
8. Market in focus
9. Parent market
10. Market characteristics
11. Product / Service portfolio of key vendors included in the market definition
12. Market segments
13. Global - Market size and forecast 2019 - 2024 ($ million)
14. Global market: Year-over-year growth 2019 - 2024 (%)
15. Five forces analysis 2019 & 2024
16. Bargaining power of buyers
17. Bargaining power of suppliers
18. Threat of new entrants
19. Threat of substitutes
20. Threat of rivalry
21. Market condition - Five forces 2019
22. Application placement - Market share 2019-2024 (%)
23. Comparison by Application placement
24. Therapeutics - Market size and forecast 2019-2024 ($ million)
25. Therapeutics - Year-over-year growth 2019-2024 (%)
26. Diagnostics - Market size and forecast 2019-2024 ($ million)
27. Diagnostics - Year-over-year growth 2019-2024 (%)
28. Market opportunity by Application
29. Customer landscape
30. Market share by geography 2019-2024 (%)
31. Geographic comparison
32. North America - Market size and forecast 2019-2024 ($ million)
33. North America - Year-over-year growth 2019-2024 (%)
34. Europe - Market size and forecast 2019-2024 ($ million)
35. Europe - Year-over-year growth 2019-2024 (%)
36. Asia - Market size and forecast 2019-2024 ($ million)
37. Asia - Year-over-year growth 2019-2024 (%)
38. ROW - Market size and forecast 2019-2024 ($ million)
39. ROW - Year-over-year growth 2019-2024 (%)
40. Key leading countries
41. Market opportunity by geography ($ million)
42. Impact of drivers
43. Impact of challenges
44. Landscape disruption
45. Industry risks
46. Vendors covered
47. Market positioning of vendors
48. 4D pharma Plc - Overview (1/3)
49. 4D pharma Plc - Overview (2/3)
50. 4D pharma Plc - Overview (3/3)
51. 4D pharma Plc - Business segments
52. 4D pharma Plc - Key offerings
53. 4D pharma Plc - Key customers
54. 4D pharma Plc - Segment focus
55. ENTEROME SA - Overview (1/3)
56. ENTEROME SA - Overview (2/3)
57. ENTEROME SA - Overview (3/3)
58. ENTEROME SA - Product and service
59. ENTEROME SA - Key offerings
60. ENTEROME SA - Key customers
61. ENTEROME SA - Segment focus
62. Evelo Biosciences Inc. - Overview (1/3)
63. Evelo Biosciences Inc. - Overview (2/3)
64. Evelo Biosciences Inc. - Overview (3/3)
65. Evelo Biosciences Inc. - Business segments
66. Evelo Biosciences Inc. - Key offerings
67. Evelo Biosciences Inc. - Key customers
68. Evelo Biosciences Inc. - Segment focus
69. Ferring International Center SA - Overview (1/3)
70. Ferring International Center SA - Overview (2/3)
71. Ferring International Center SA - Overview (3/3)
72. Ferring International Center SA - Product and service
73. Ferring International Center SA - Key offerings
74. Ferring International Center SA - Key customers
75. Ferring International Center SA - Segment focus
76. Osel Inc. - Overview (1/3)
77. Osel Inc. - Overview (2/3)
78. Osel Inc. - Overview (3/3)
79. Osel Inc. - Product and service
80. Osel Inc. - Key offerings
81. Osel Inc. - Key customers
82. Osel Inc. - Segment focus
83. Second Genome Inc. - Overview (1/3)
84. Second Genome Inc. - Overview (2/3)
85. Second Genome Inc. - Overview (3/3)
86. Second Genome Inc. - Product and service
87. Second Genome Inc. - Key offerings
88. Second Genome Inc. - Key customers
89. Second Genome Inc. - Segment focus
90. Seres Therapeutics Inc. - Overview (1/3)
91. Seres Therapeutics Inc. - Overview (2/3)
92. Seres Therapeutics Inc. - Overview (3/3)
93. Seres Therapeutics Inc. - Business segments
94. Seres Therapeutics Inc. - Key offerings
95. Seres Therapeutics Inc. - Key customers
96. Seres Therapeutics Inc. - Segment focus
97. Synlogic Inc. - Overview (1/3)
98. Synlogic Inc. - Overview (2/3)
99. Synlogic Inc. - Overview (3/3)
100. Synlogic Inc. - Business segments
101. Synlogic Inc. - Key offerings
102. Synlogic Inc. - Key customers
103. Synlogic Inc. - Segment focus
104. Synthetic Biologics Inc. - Overview (1/3)
105. Synthetic Biologics Inc. - Overview (2/3)
106. Synthetic Biologics Inc. - Overview (3/3)
107. Synthetic Biologics Inc. - Product and service
108. Synthetic Biologics Inc. - Key offerings
109. Synthetic Biologics Inc. - Key customers
110. Synthetic Biologics Inc. - Segment focus
111. Vedanta Biosciences Inc. - Overview (1/3)
112. Vedanta Biosciences Inc. - Overview (2/3)
113. Vedanta Biosciences Inc. - Overview (3/3)
114. Vedanta Biosciences Inc. - Product and service
115. Vedanta Biosciences Inc. - Key offerings
116. Vedanta Biosciences Inc. - Key customers
117. Vedanta Biosciences Inc. - Segment focus
118. Currency conversion rates for US$
119. Research Methodology
120. Validation techniques employed for market sizing
121. Information sources
122. List of abbreviations
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • 4D pharma Plc
  • ENTEROME SA
  • Evelo Biosciences Inc.
  • Osel Inc.
  • Second Genome Inc.
  • Seres Therapeutics Inc.
  • MORE
The publisher Announces the Publication of its Research Report-Global Microbiomes Market 2020-2024.

The publisher recognizes the following companies as the key players in the global microbiomes market: 4D pharma Plc, ENTEROME SA, Evelo Biosciences Inc., Ferring International Center SA, Osel Inc., Second Genome Inc., Seres Therapeutics Inc., Synlogic Inc., Synthetic Biologics Inc. and Vedanta Biosciences Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is the growing focus on developing biosensors and genetic circuits."

According to the report, one of the major drivers for this market is the increasing prevalence of diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • 4D pharma Plc
  • ENTEROME SA
  • Evelo Biosciences Inc.
  • Ferring International Center SA
  • Osel Inc.
  • Second Genome Inc.
  • Seres Therapeutics Inc.
  • Synlogic Inc.
  • Synthetic Biologics Inc.
  • Vedanta Biosciences Inc.
Note: Product cover images may vary from those shown
Adroll
adroll